Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Otorhinolaryngology

  Free Subscription


Articles published in Oral Oncol

Retrieve available abstracts of 239 articles:
HTML format
Text format



Single Articles


    May 2019
  1. ABRAM TJ, Floriano PN, James R, Kerr AR, et al
    Development of a cytology-based multivariate analytical risk index for oral cancer.
    Oral Oncol. 2019;92:6-11.
    PubMed     Text format     Abstract available


  2. LIANG YJ, Sun XS, Yang ZC, Tang QN, et al
    Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patients.
    Oral Oncol. 2019;92:40-45.
    PubMed     Text format     Abstract available


  3. GREENE S, Patel P, Allen CT
    How patients with an intact immune system develop head and neck cancer.
    Oral Oncol. 2019;92:26-32.
    PubMed     Text format     Abstract available


  4. SUNNY SP, Agarwal S, James BL, Heidari E, et al
    Intra-operative point-of-procedure delineation of oral cancer margins using optical coherence tomography.
    Oral Oncol. 2019;92:12-19.
    PubMed     Text format     Abstract available


  5. SMITH WH, Luskin I, Resende Salgado L, Scarborough BM, et al
    Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies.
    Oral Oncol. 2019;92:1-5.
    PubMed     Text format     Abstract available


    April 2019
  6. HARTMAN DJ, Ahmad FS, Ferris RL, Rimm DL, et al
    Corrigendum to "Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma" [Oral Oncol. 86 (2018) 278-287].
    Oral Oncol. 2019 Apr 30. pii: S1368-8375(19)30128.
    PubMed     Text format    


  7. DE FELICE F, Polimeni A, Tombolini V
    Human papillomavirus (HPV) vaccine and HPV-related head and neck cancer: What's next?
    Oral Oncol. 2019 Apr 4. pii: S1368-8375(19)30101.
    PubMed     Text format    


  8. CHAN JYW, Wong STS, Wei WI
    Surgical salvage of recurrent T3 nasopharyngeal carcinoma: Prognostic significance of clivus, maxillary, temporal and sphenoid bone invasion.
    Oral Oncol. 2019;91:85-91.
    PubMed     Text format     Abstract available


  9. LUO WJ, Feng YF, Guo R, Tang LL, et al
    Patterns of EBV-positive cervical lymph node involvement in head and neck cancer and implications for the management of nasopharyngeal carcinoma T0 classification.
    Oral Oncol. 2019;91:7-12.
    PubMed     Text format     Abstract available


  10. EZE N, Lee JW, Yang DH, Zhu F, et al
    PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma.
    Oral Oncol. 2019;91:69-78.
    PubMed     Text format     Abstract available


  11. TSAI MS, Chen WC, Lu CH, Chen MF, et al
    The prognosis of head and neck squamous cell carcinoma related to immunosuppressive tumor microenvironment regulated by IL-6 signaling.
    Oral Oncol. 2019;91:47-55.
    PubMed     Text format     Abstract available


  12. GUY JB, Benna M, Xia Y, Daguenet E, et al
    Quality insurance in head and neck cancer multidisciplinary team meetings: A watchful eye on real-life experience.
    Oral Oncol. 2019;91:35-38.
    PubMed     Text format     Abstract available


  13. SONG E, Ahn J, Oh HS, Jeon MJ, et al
    Time trends of thyroglobulin antibody in ablated papillary thyroid carcinoma patients: Can we predict the rate of negative conversion?
    Oral Oncol. 2019;91:29-34.
    PubMed     Text format     Abstract available


  14. GUO Q, Lu T, Hui Huang S, O'Sullivan B, et al
    Depicting distant metastatic risk by refined subgroups derived from the 8th edition nasopharyngeal carcinoma TNM.
    Oral Oncol. 2019;91:113-120.
    PubMed     Text format     Abstract available


    March 2019
  15. DE BREE R, Takes RP, Shah JP, Hamoir M, et al
    Elective neck dissection in oral squamous cell carcinoma: Past, present and future.
    Oral Oncol. 2019;90:87-93.
    PubMed     Text format     Abstract available


  16. EL-SALEM F, Mansour M, Gitman M, Miles BA, et al
    Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: Exposing the limitations of conventional p16 immunostaining.
    Oral Oncol. 2019;90:74-79.
    PubMed     Text format     Abstract available


  17. GHANIZADA M, Jakobsen KK, Gronhoj C, von Buchwald C, et al
    The effects of checkpoint inhibition on head and neck squamous cell carcinoma: A systematic review.
    Oral Oncol. 2019;90:67-73.
    PubMed     Text format     Abstract available


  18. KANG S
    Organ preservation in laryngeal and hypopharyngeal cancer.
    Oral Oncol. 2019;90:6-7.
    PubMed     Text format    


  19. GUPTA A, Stokes W, Eguchi M, Hararah M, et al
    Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer.
    Oral Oncol. 2019;90:54-66.
    PubMed     Text format     Abstract available


  20. YUNG CS, Leung DKC, Cheung JPY
    The prevalence and impact of cervical spine pathologies in patients with nasopharyngeal carcinoma.
    Oral Oncol. 2019;90:48-53.
    PubMed     Text format     Abstract available


  21. FRIEDMAN J, Padget M, Lee J, Schlom J, et al
    Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells.
    Oral Oncol. 2019;90:38-44.
    PubMed     Text format     Abstract available


  22. WANG YQ, Lv JW, Tang LL, Du XJ, et al
    Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual.
    Oral Oncol. 2019;90:23-29.
    PubMed     Text format     Abstract available


  23. LIU J, Zhang Z, Huang H, Xu S, et al
    Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
    Oral Oncol. 2019;90:17-22.
    PubMed     Text format     Abstract available


  24. GARCIA GCTE, Gorphe P, Hartl D, Ammari S, et al
    Computed tomography evaluation after induction chemotherapy for T3 laryngeal cancer: Does response correlate with vocal cord mobility?
    Oral Oncol. 2019;90:13-16.
    PubMed     Text format     Abstract available


  25. BADR H, Sobrero M, Chen J, Kotz T, et al
    Associations between pre-, post-, and peri-operative variables and health resource use following surgery for head and neck cancer.
    Oral Oncol. 2019;90:102-108.
    PubMed     Text format     Abstract available


  26. MIAO J, Wang L, Zhu M, Xiao W, et al
    Corrigendum to "Long-term survival and late toxicities of elderly nasopharyngeal carcinoma (NPC) patients treated by high-total- and fractionated-dose simultaneous modulated accelerated radiotherapy with or without chemotherapy" [Oral Oncol. 89 (2019)
    Oral Oncol. 2019;90:136.
    PubMed     Text format    


  27. MIAO J, Wang L, Zhu M, Xiao W, et al
    Reprint of Long-term survival and late toxicities of elderly nasopharyngeal carcinoma (NPC) patients treated by high-total- and fractionated-dose simultaneous modulated accelerated radiotherapy with or without chemotherapy.
    Oral Oncol. 2019;90:126-133.
    PubMed     Text format     Abstract available


    February 2019
  28. SALEH K, Saada E, Auger N, Mayache-Badis L, et al
    Successful treatment with trastuzumab in HER2-positive squamous cell carcinoma of the head and neck.
    Oral Oncol. 2019 Feb 14. pii: S1368-8375(19)30044.
    PubMed     Text format    


  29. YU ST, Xiao ZZ
    Letter to the Editor regarding, "Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis".
    Oral Oncol. 2019 Feb 14. pii: S1368-8375(19)30045.
    PubMed     Text format    


  30. GAUBATZ ME, Bukatko AR, Simpson MC, Polednik KM, et al
    Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States.
    Oral Oncol. 2019;89:95-101.
    PubMed     Text format     Abstract available


  31. CHUNG EJ, Jeong WJ, Jung YH, Kwon SK, et al
    Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases.
    Oral Oncol. 2019;89:84-94.
    PubMed     Text format     Abstract available


  32. NAM KIM Y, Kim M, Seon Ahn H, Kim K, et al
    Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma.
    Oral Oncol. 2019;89:8-13.
    PubMed     Text format     Abstract available


  33. TEFT WA, Winquist E, Nichols AC, Kuruvilla S, et al
    Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients.
    Oral Oncol. 2019;89:72-78.
    PubMed     Text format     Abstract available


  34. HUANG CC, Lin CN, Chung CH, Hwang JS, et al
    Cost-effectiveness analysis of the oral cancer screening program in Taiwan.
    Oral Oncol. 2019;89:59-65.
    PubMed     Text format     Abstract available


  35. JACOBS CD, Barbour AB, Mowery YM
    The relative distribution of oral cancer in the United States by subsite.
    Oral Oncol. 2019;89:56-58.
    PubMed     Text format    


  36. SIMPSON MC, Challapalli SD, Cass LM, Zahirsha ZS, et al
    Impact of gender on the association between marital status and head and neck cancer outcomes.
    Oral Oncol. 2019;89:48-55.
    PubMed     Text format     Abstract available


  37. MIAO J, Wang L, Zhu M, Xiao W, et al
    Long-term survival and late toxicities of elderly nasopharyngeal carcinoma (NPC) patients treated by high-total- and fractionated-dose simultaneous modulated accelerated radiotherapy with or without chemotherapy.
    Oral Oncol. 2019;89:40-47.
    PubMed     Text format    


  38. CHIKAMATSU K, Tada H, Takahashi H, Kuwabara-Yokobori Y, et al
    Expression of immune-regulatory molecules in circulating tumor cells derived from patients with head and neck squamous cell carcinoma.
    Oral Oncol. 2019;89:34-39.
    PubMed     Text format     Abstract available


  39. HEALY CM, Moran GP
    The microbiome and oral cancer: More questions than answers.
    Oral Oncol. 2019;89:30-33.
    PubMed     Text format     Abstract available


  40. FARQUHAR DR, Masood MM, Lenze NR, McDaniel P, et al
    Travel time to provider is associated with advanced stage at diagnosis among low income head and neck squamous cell carcinoma patients in North Carolina.
    Oral Oncol. 2019;89:115-120.
    PubMed     Text format     Abstract available


  41. PENG L, Xu C, Chen YP, Guo R, et al
    Optimizing the cumulative cisplatin dose during radiotherapy in nasopharyngeal carcinoma: Dose-effect analysis for a large cohort.
    Oral Oncol. 2019;89:102-106.
    PubMed     Text format     Abstract available


    January 2019
  42. PAOLINI F, Bonomo C, Terrenato I, Pennetti A, et al
    Beta human papillomaviruses in middle ear squamous cell carcinoma.
    Oral Oncol. 2019 Jan 18. pii: S1368-8375(19)30004.
    PubMed     Text format    


  43. JAYARAJ R, Kumarasamy C
    Conceptual interpretation of analysing and reporting of results on systematic review and meta-analysis of optimal extent of lateral neck dissection for well-differentiated thyroid carcinoma with metastatic lateral neck lymph nodes.
    Oral Oncol. 2019 Jan 3. pii: S1368-8375(18)30497.
    PubMed     Text format    


  44. FOY JP, Bertolus C, Saintigny P
    Oral cancer prevention worldwide: Challenges and perspectives.
    Oral Oncol. 2019;88:91-94.
    PubMed     Text format    


  45. HAQUE S, Karivedu V, Riaz MK, Choi D, et al
    High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.
    Oral Oncol. 2019;88:9-15.
    PubMed     Text format     Abstract available


  46. MAY ME JR, Cash ED, Silverman CL, Redman RA, et al
    Prognostic factors and selection criteria in the retreatment of head and neck cancers.
    Oral Oncol. 2019;88:85-90.
    PubMed     Text format     Abstract available


  47. ALTAMURA G, Borzacchiello G
    HPV related head and neck squamous cell carcinoma: New evidences for an emerging spontaneous animal model.
    Oral Oncol. 2019;88:84.
    PubMed     Text format    


  48. MARTENS RM, Noij DP, Ali M, Koopman T, et al
    Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review.
    Oral Oncol. 2019;88:75-83.
    PubMed     Text format     Abstract available


  49. MORENO AC, Frank SJ, Garden AS, Rosenthal DI, et al
    Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
    Oral Oncol. 2019;88:66-74.
    PubMed     Text format     Abstract available


  50. GREGOIRE V, Ng WT
    Special section on intensity-modulated radiation therapy for head and neck cancer (IMRT).
    Oral Oncol. 2019;88:49-50.
    PubMed     Text format    


  51. GOEL AN, Frangos MI, Raghavan G, Lazaro SL, et al
    The impact of treatment package time on survival in surgically managed head and neck cancer in the United States.
    Oral Oncol. 2019;88:39-48.
    PubMed     Text format     Abstract available


  52. EVRARD D, Szturz P, Tijeras-Raballand A, Astorgues-Xerri L, et al
    Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy.
    Oral Oncol. 2019;88:29-38.
    PubMed     Text format     Abstract available


  53. SHETTY SS, Vishal Rao US
    8 "S" in oral cancer.
    Oral Oncol. 2019;88:27-28.
    PubMed     Text format    


  54. KARSTEN RT, Stuiver MM, van der Molen L, Navran A, et al
    From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approach.
    Oral Oncol. 2019;88:172-179.
    PubMed     Text format     Abstract available


  55. LIU JC, Bhayani M, Kuchta K, Galloway T, et al
    Patterns of distant metastasis in head and neck cancer at presentation: Implications for initial evaluation.
    Oral Oncol. 2019;88:131-136.
    PubMed     Text format     Abstract available


  56. KIM Y, Roh JL, Kim JS, Lee JH, et al
    Chest radiography or chest CT plus head and neck CT versus (18)F-FDG PET/CT for detection of distant metastasis and synchronous cancer in patients with head and neck cancer.
    Oral Oncol. 2019;88:109-114.
    PubMed     Text format     Abstract available


  57. FENG RM, Chang ET, Liu Z, Liu Q, et al
    Reproductive history and risk of nasopharyngeal carcinoma: A population-based case-control study in southern China.
    Oral Oncol. 2019;88:102-108.
    PubMed     Text format     Abstract available


    December 2018
  58. JAYARAJ R, Kumarasamy C
    Letter to the Editor about the Article: "Performance of different imaging techniques in the diagnosis of head and neck cancer mandibular invasion: A systematic review and meta-analysis".
    Oral Oncol. 2018 Dec 31. pii: S1368-8375(18)30490.
    PubMed     Text format    


  59. JAYARAJ R, Kumarasamy C, Samiappan S, Swaminathan P, et al
    Letter to the Editor regarding, "The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis".
    Oral Oncol. 2018 Dec 19. pii: S1368-8375(18)30482.
    PubMed     Text format    


  60. DENG L, Cao Y, Lin J
    Regional recurrence rate of lymph-node-positive thyroid carcinoma after selective or comprehensive neck dissection.
    Oral Oncol. 2018 Dec 13. pii: S1368-8375(18)30456.
    PubMed     Text format    


  61. KIM M, Kim HI, Jeon MJ, Kim HK, et al
    Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.
    Oral Oncol. 2018;87:97-103.
    PubMed     Text format     Abstract available


  62. BAIRD BJ, Sung CK, Beadle BM, Divi V, et al
    Treatment of early-stage laryngeal cancer: A comparison of treatment options.
    Oral Oncol. 2018;87:8-16.
    PubMed     Text format     Abstract available


  63. MCCLELLAND S 3RD, Andrews JZ, Chaudhry H, Teckie S, et al
    Prophylactic versus reactive gastrostomy tube placement in advanced head and neck cancer treated with definitive chemoradiotherapy: A systematic review.
    Oral Oncol. 2018;87:77-81.
    PubMed     Text format     Abstract available


  64. D'CRUZ AK, Vaish R, Dhar H
    Oral cancers: Current status.
    Oral Oncol. 2018;87:64-69.
    PubMed     Text format     Abstract available


  65. CHUANG SL, Wang CP, Chen MK, Su WW, et al
    Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program.
    Oral Oncol. 2018;87:58-63.
    PubMed     Text format     Abstract available


  66. TANAKA N, Osman AA, Takahashi Y, Lindemann A, et al
    Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
    Oral Oncol. 2018;87:49-57.
    PubMed     Text format     Abstract available


  67. DUA B, Chufal KS, Bhatnagar A, Thakwani A, et al
    Nodal volume as a prognostic factor in locally advanced head and neck cancer: Identifying candidates for elective neck dissection after chemoradiation with IGRT from a single institutional prospective series from the Indian subcontinent.
    Oral Oncol. 2018;87:179-185.
    PubMed     Text format     Abstract available


  68. OLATUNJI I
    Potential application of tumor suppressor microRNAs for targeted therapy in head and neck cancer: A mini-review.
    Oral Oncol. 2018;87:165-169.
    PubMed     Text format     Abstract available


  69. NAM SH, Bae MR, Roh JL, Gong G, et al
    A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Oral Oncol. 2018;87:158-164.
    PubMed     Text format     Abstract available


  70. RANGEL JB, Thuler LCS, Pinto JFDC
    Prevalence of hepatitis C virus infection and its impact on the prognosis of head and neck cancer patients.
    Oral Oncol. 2018;87:138-143.
    PubMed     Text format     Abstract available


  71. WON HR, Chang JW, Kang YE, Kang JY, et al
    Optimal extent of lateral neck dissection for well-differentiated thyroid carcinoma with metastatic lateral neck lymph nodes: A systematic review and meta-analysis.
    Oral Oncol. 2018;87:117-125.
    PubMed     Text format     Abstract available


  72. KEARNEY V, Chan JW, Valdes G, Solberg TD, et al
    The application of artificial intelligence in the IMRT planning process for head and neck cancer.
    Oral Oncol. 2018;87:111-116.
    PubMed     Text format     Abstract available


  73. HIRSCHMANN A, Lupatsch JE, Schwenkglenks M, Panje CM, et al
    Cost-effectiveness of nivolumab in the treatment of head and neck cancer.
    Oral Oncol. 2018;87:104-110.
    PubMed     Text format     Abstract available


    November 2018
  74. HUANG NS, Wei WJ, Qu N, Wang YL, et al
    Lingual ectopic papillary thyroid carcinoma: Two case reports and review of the literature.
    Oral Oncol. 2018 Nov 22. pii: S1368-8375(18)30428.
    PubMed     Text format     Abstract available


  75. LIU W, Chen S, Yang W
    The diverse cutoff of PD-L1 positivity and negativity in studies regarding head and neck squamous cell carcinoma.
    Oral Oncol. 2018 Nov 2. pii: S1368-8375(18)30404.
    PubMed     Text format    


  76. ANDREASSEN CN, Eriksen JG, Jensen K, Hansen CR, et al
    IMRT - Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer.
    Oral Oncol. 2018;86:91-99.
    PubMed     Text format     Abstract available


  77. YANG WF, Wong MCM, Thomson PJ, Li KY, et al
    The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Oral Oncol. 2018;86:81-90.
    PubMed     Text format     Abstract available


  78. KIM M, Kim HK, Kim HI, Kim EH, et al
    Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
    Oral Oncol. 2018;86:48-52.
    PubMed     Text format     Abstract available


  79. BONOMI MR, Blakaj A, Blakaj D
    Organ preservation for advanced larynx cancer: A review of chemotherapy and radiation combination strategies.
    Oral Oncol. 2018;86:301-306.
    PubMed     Text format     Abstract available


  80. EVANS M, Beasley M
    Target delineation for postoperative treatment of head and neck cancer.
    Oral Oncol. 2018;86:288-295.
    PubMed     Text format     Abstract available


  81. HARTMAN DJ, Ahmad F, Ferris RL, Rimm DL, et al
    Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma.
    Oral Oncol. 2018;86:278-287.
    PubMed     Text format     Abstract available


  82. PENG L, Chen YP, Xu C, Tang LL, et al
    A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II-IVa nasopharyngeal carcinoma.
    Oral Oncol. 2018;86:258-265.
    PubMed     Text format     Abstract available


  83. FUJIWARA T, Eguchi T, Sogawa C, Ono K, et al
    Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab.
    Oral Oncol. 2018;86:251-257.
    PubMed     Text format     Abstract available


  84. SEGRELLES C, Paramio JM, Lorz C
    The transcriptional co-activator YAP: A new player in head and neck cancer.
    Oral Oncol. 2018;86:25-32.
    PubMed     Text format     Abstract available


  85. GARNEAU JC, Bakst RL, Miles BA
    Hypopharyngeal cancer: A state of the art review.
    Oral Oncol. 2018;86:244-250.
    PubMed     Text format     Abstract available


  86. KASHYAP T, Pramanik KK, Nath N, Mishra P, et al
    Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3beta signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
    Oral Oncol. 2018;86:234-243.
    PubMed     Text format     Abstract available


  87. GUJRAL DM, Nutting CM
    Patterns of failure, treatment outcomes and late toxicities of head and neck cancer in the current era of IMRT.
    Oral Oncol. 2018;86:225-233.
    PubMed     Text format     Abstract available


  88. SPECTOR ME, Rosko AJ, Swiecicki PL, Chad Brenner J, et al
    From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer.
    Oral Oncol. 2018;86:200-205.
    PubMed     Text format     Abstract available


  89. ESKANDER A, Blakaj DM, Dziegielewski PT
    Decision making in advanced larynx cancer: An evidenced based review.
    Oral Oncol. 2018;86:195-199.
    PubMed     Text format     Abstract available


  90. GENSHEIMER MF, Le QT
    Adaptive radiotherapy for head and neck cancer: Are we ready to put it into routine clinical practice?
    Oral Oncol. 2018;86:19-24.
    PubMed     Text format     Abstract available


  91. QIAO X, Liu W, Cao Y, Miao C, et al
    Performance of different imaging techniques in the diagnosis of head and neck cancer mandibular invasion: A systematic review and meta-analysis.
    Oral Oncol. 2018;86:150-164.
    PubMed     Text format     Abstract available


  92. CHUANG HC, Chou MH, Chien CY, Chuang JH, et al
    Triggering TLR3 pathway promotes tumor growth and cisplatin resistance in head and neck cancer cells.
    Oral Oncol. 2018;86:141-149.
    PubMed     Text format     Abstract available


  93. ZANDBERG DP, Cullen K, Bentzen SM, Goloubeva OG, et al
    Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.
    Oral Oncol. 2018;86:132-140.
    PubMed     Text format     Abstract available


  94. SHAIKH MH, Idris A, Johnson NW, Fallaha S, et al
    Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.
    Oral Oncol. 2018;86:105-112.
    PubMed     Text format     Abstract available


  95. DO JH, Yoon IJ, Cho YK, Ahn JS, et al
    Comparison of hospital based and home based exercise on quality of life, and neck and shoulder function in patients with spinal accessary nerve injury after head and neck cancer surgery.
    Oral Oncol. 2018;86:100-104.
    PubMed     Text format     Abstract available


    October 2018
  96. CAPPELLI E, Degan P, Dufour C, Ravera S, et al
    Aerobic metabolism dysfunction as one of the links between Fanconi anemia-deficient pathway and the aggressive cell invasion in head and neck cancer cells.
    Oral Oncol. 2018 Oct 20. pii: S1368-8375(18)30370.
    PubMed     Text format    


  97. SHETTY SS, Vishal Rao US
    Changing sexual practices: A possible link to oral cancer.
    Oral Oncol. 2018 Oct 10. pii: S1368-8375(18)30356.
    PubMed     Text format    


  98. LI PJ, Mo HY, Luo DH, Hu WH, et al
    The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
    Oral Oncol. 2018;85:95-100.
    PubMed     Text format     Abstract available


  99. AMBATIPUDI S, Langdon R, Richmond RC, Suderman M, et al
    DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival.
    Oral Oncol. 2018;85:87-94.
    PubMed     Text format     Abstract available


  100. LU L, Sheng Y, Zhang G, Li Y, et al
    Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
    Oral Oncol. 2018;85:8-14.
    PubMed     Text format     Abstract available


  101. SAKA HERRAN C, Jane-Salas E, Estrugo Devesa A, Lopez-Lopez J, et al
    Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
    Oral Oncol. 2018;85:68-81.
    PubMed     Text format     Abstract available


  102. CHEN JJ, Harris JP, Kong CS, Sunwoo JB, et al
    Clinical perineural invasion of cutaneous head and neck cancer: Impact of radiotherapy, imaging, and nerve growth factor receptors on symptom control and prognosis.
    Oral Oncol. 2018;85:60-67.
    PubMed     Text format     Abstract available


  103. LEE DJ, Eun YG, Rho YS, Kim EH, et al
    Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.
    Oral Oncol. 2018;85:44-51.
    PubMed     Text format     Abstract available


  104. LIN DJ, McConkey CC, Nankivell P, Dunn J, et al
    The impact of institutional clinical trial recruitment versus hospital volume on survival outcomes of patients with head and neck cancer: An analysis of the PET-NECK trial outcomes, UKCRN portfolio, and Hospital Episode Statistics (HES) in England.
    Oral Oncol. 2018;85:40-43.
    PubMed     Text format     Abstract available


  105. SRIDHARAN V, Rahman RM, Huang RY, Chau NG, et al
    Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.
    Oral Oncol. 2018;85:29-34.
    PubMed     Text format     Abstract available


    September 2018
  106. MORAND GB, Helmchen BM, Steinert HC, Schmid C, et al
    18F-Choline-PET in parathyroid carcinoma.
    Oral Oncol. 2018 Sep 28. pii: S1368-8375(18)30324.
    PubMed     Text format    


  107. PANTA P
    'Meditation Training Intervention' - A necessary shift for head and neck cancer patients.
    Oral Oncol. 2018 Sep 8. pii: S1368-8375(18)30316.
    PubMed     Text format    


  108. SALOURA V, Vougiouklakis T, Burkitt K, Nakamura Y, et al
    Corrigendum to "The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck" [Oral Oncol. 81 (2018) 100-108].
    Oral Oncol. 2018 Sep 7. pii: S1368-8375(18)30313.
    PubMed     Text format    


  109. DRONKERS EAC, Hoesseini A, de Boer MF, Offerman MPJ, et al
    Communication of prognosis in head and neck cancer patients; a descriptive qualitative analysis.
    Oral Oncol. 2018;84:76-81.
    PubMed     Text format     Abstract available


  110. CHEN MM, Colevas AD, Megwalu U, Divi V, et al
    Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Oral Oncol. 2018;84:71-75.
    PubMed     Text format     Abstract available


  111. FARQUHAR DR, Tanner AM, Masood MM, Patel SR, et al
    Oral tongue carcinoma among young patients: An analysis of risk factors and survival.
    Oral Oncol. 2018;84:7-11.
    PubMed     Text format     Abstract available


  112. WEISS J, Gilbert J, Deal AM, Weissler M, et al
    Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck.
    Oral Oncol. 2018;84:46-51.
    PubMed     Text format     Abstract available


  113. PARK SY, Kim HI, Choi JY, Choe JH, et al
    Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles.
    Oral Oncol. 2018;84:41-45.
    PubMed     Text format     Abstract available


  114. PENG LC, Hui X, Cheng Z, Bowers MR, et al
    Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.
    Oral Oncol. 2018;84:25-30.
    PubMed     Text format     Abstract available


  115. STOKES WA, Eguchi M, Amini A, Hararah MK, et al
    Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
    Oral Oncol. 2018;84:12-19.
    PubMed     Text format     Abstract available


  116. LALA M, Chirovsky D, Cheng JD, Mayawala K, et al
    Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review.
    Oral Oncol. 2018;84:108-120.
    PubMed     Text format     Abstract available


  117. LI Y, Xu T, Qian W, Lu X, et al
    Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
    Oral Oncol. 2018;84:1-6.
    PubMed     Text format     Abstract available


    August 2018
  118. ANGELIDAKIS G, Sturgis EM, Economides MP, Jiang Y, et al
    Chronic hepatitis C virus infection on patients with nonoropharyngeal head and neck cancers.
    Oral Oncol. 2018 Aug 25. pii: S1368-8375(18)30303.
    PubMed     Text format    


  119. PATTERSON JM, McColl E, Carding PN, Wilson JA, et al
    Swallowing beyond six years post (chemo)radiotherapy for head and neck cancer; a cohort study.
    Oral Oncol. 2018;83:53-58.
    PubMed     Text format     Abstract available


  120. CHOI N, Park SI, Kim H, Sohn I, et al
    The impact of unplanned reoperations in head and neck cancer surgery on survival.
    Oral Oncol. 2018;83:38-45.
    PubMed     Text format     Abstract available


  121. LECHNER M, Chakravarthy AR, Walter V, Masterson L, et al
    Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
    Oral Oncol. 2018;83:32-37.
    PubMed     Text format     Abstract available


  122. MELISSANT HC, Jansen F, Schutte LER, Lissenberg-Witte BI, et al
    The course of sexual interest and enjoyment in head and neck cancer patients treated with primary (chemo)radiotherapy.
    Oral Oncol. 2018;83:120-126.
    PubMed     Text format     Abstract available


  123. HICKS DF, Bakst R, Doucette J, Kann BH, et al
    Impact of obesity on outcomes for patients with head and neck cancer.
    Oral Oncol. 2018;83:11-17.
    PubMed     Text format     Abstract available


  124. ESKANDER A, Krzyzanowska MK, Fischer HD, Liu N, et al
    Emergency department visits and unplanned hospitalizations in the treatment period for head and neck cancer patients treated with curative intent: A population-based analysis.
    Oral Oncol. 2018;83:107-114.
    PubMed     Text format     Abstract available


  125. WILKIE MD, Lau AS, Vlatkovic N, Jones TM, et al
    Metabolic signature of squamous cell carcinoma of the head and neck: Consequences of TP53 mutation and therapeutic perspectives.
    Oral Oncol. 2018;83:1-10.
    PubMed     Text format     Abstract available


    July 2018
  126. DE BREE R, de Keizer B
    Is there a place for FDG-PET-CT in early oral cancer patients?
    Oral Oncol. 2018 Jul 31. pii: S1368-8375(18)30276.
    PubMed     Text format    


  127. FERRAROTTO R, William WN Jr, Tseng JE, Marur S, et al
    Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2018;82:83-90.
    PubMed     Text format     Abstract available


  128. RETTIG EM, Bishop JA, Agrawal N, Chung CH, et al
    HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.
    Oral Oncol. 2018;82:168-175.
    PubMed     Text format     Abstract available


  129. HOROWITZ G, Hosni A, Yu E, Xu W, et al
    Prevalence, prognosis, and treatment implications of retropharyngeal nodes in unknown primary head and neck carcinoma.
    Oral Oncol. 2018;82:162-167.
    PubMed     Text format     Abstract available


  130. SIANO M, Espeli V, Mach N, Bossi P, et al
    Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial.
    Oral Oncol. 2018;82:144-151.
    PubMed     Text format     Abstract available


  131. MASSA ST, Rohde RL, Mckinstry C, Gresham M, et al
    An assessment of patient burdens from head and neck cancer survivorship care.
    Oral Oncol. 2018;82:115-121.
    PubMed     Text format     Abstract available


  132. PENG YL, Chen L, Shen GZ, Li YN, et al
    Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity-modulated radiation therapy for nasopharyngeal carcinoma.
    Oral Oncol. 2018;82:1-7.
    PubMed     Text format     Abstract available


    June 2018
  133. MAIR MD, Shetty R, Nair D, Mathur Y, et al
    Depth of invasion, size and number of metastatic nodes predicts extracapsular spread in early oral cancers with occult metastases.
    Oral Oncol. 2018;81:95-99.
    PubMed     Text format     Abstract available


  134. YUE Q, Zhang M, Chen Y, Zheng D, et al
    Establishment of prognostic factors in recurrent nasopharyngeal carcinoma patients who received salvage intensity-modulated radiotherapy: A meta-analysis.
    Oral Oncol. 2018;81:81-88.
    PubMed     Text format     Abstract available


  135. MOTT FE, Ferrarotto R, Nguyen T, Phan J, et al
    Nasopharyngeal carcinoma outcome with induction chemotherapy followed by concurrent chemoradiotherapy.
    Oral Oncol. 2018;81:75-80.
    PubMed     Text format     Abstract available


  136. RASMUSSEN JH, Hakansson K, Rasmussen GB, Vogelius IR, et al
    A clinical prognostic model compared to the newly adopted UICC staging in an independent validation cohort of P16 negative/positive head and neck cancer patients.
    Oral Oncol. 2018;81:52-60.
    PubMed     Text format     Abstract available


  137. FERRIS RL, Blumenschein G Jr, Fayette J, Guigay J, et al
    Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.
    Oral Oncol. 2018;81:45-51.
    PubMed     Text format     Abstract available


  138. OSAZUWA-PETERS N, Arnold LD, Loux TM, Varvares MA, et al
    Factors associated with increased risk of suicide among survivors of head and neck cancer: A population-based analysis.
    Oral Oncol. 2018;81:29-34.
    PubMed     Text format     Abstract available


  139. KRAEIMA J, Dorgelo B, Gulbitti HA, Steenbakkers RJHM, et al
    Multi-modality 3D mandibular resection planning in head and neck cancer using CT and MRI data fusion: A clinical series.
    Oral Oncol. 2018;81:22-28.
    PubMed     Text format     Abstract available


  140. LIN MC, Shueng PW, Chang WK, Mu-Hsin Chang P, et al
    Consensus and clinical recommendations for nutritional intervention for head and neck cancer patients undergoing chemoradiotherapy in Taiwan.
    Oral Oncol. 2018;81:16-21.
    PubMed     Text format     Abstract available


  141. SALOURA V, Vougiouklakis T, Sievers C, Burkitt K, et al
    The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck.
    Oral Oncol. 2018;81:100-108.
    PubMed     Text format     Abstract available


  142. HANNA GJ, Kofman ER, Shazib MA, Woo SB, et al
    Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors.
    Oral Oncol. 2018;81:1-9.
    PubMed     Text format     Abstract available


    May 2018
  143. CARPENTER DJ, Mowery YM, Broadwater G, Rodrigues A, et al
    The risk of carotid stenosis in head and neck cancer patients after radiation therapy.
    Oral Oncol. 2018;80:9-15.
    PubMed     Text format     Abstract available


  144. BASHEER HA, Pakanavicius E, Cooper PA, Shnyder SD, et al
    Hypoxia modulates CCR7 expression in head and neck cancers.
    Oral Oncol. 2018;80:64-73.
    PubMed     Text format     Abstract available


  145. NULTON TJ, Kim NK, DiNardo LJ, Morgan IM, et al
    Patients with integrated HPV16 in head and neck cancer show poor survival.
    Oral Oncol. 2018;80:52-55.
    PubMed     Text format     Abstract available


  146. IOCCA O, Farcomeni A, Di Rocco A, Di Maio P, et al
    Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options.
    Oral Oncol. 2018;80:40-51.
    PubMed     Text format     Abstract available


  147. HANEMAAIJER SH, van Gijn SE, Oosting SF, Plaat BEC, et al
    Data-Driven prioritisation of antibody-drug conjugate targets in head and neck squamous cell carcinoma.
    Oral Oncol. 2018;80:33-39.
    PubMed     Text format     Abstract available


  148. LIN M, You R, Liu YP, Zhang YN, et al
    Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma.
    Oral Oncol. 2018;80:1-8.
    PubMed     Text format     Abstract available


    April 2018
  149. TARDY MP, Di Mauro I, Ebran N, Refae S, et al
    Microsatellite instability associated with durable complete response to PD-L1 inhibitor in head and neck squamous cell carcinoma.
    Oral Oncol. 2018 Apr 6. pii: S1368-8375(18)30124.
    PubMed     Text format    


  150. GARCIA-ESCUDERO R, Segrelles C, Duenas M, Pombo M, et al
    Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
    Oral Oncol. 2018;79:55-63.
    PubMed     Text format     Abstract available


  151. PENG H, Tang LL, Chen BB, Chen L, et al
    Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma: A big-data intelligence platform-based analysis.
    Oral Oncol. 2018;79:40-46.
    PubMed     Text format     Abstract available


  152. CAO C, Jiang F, Jin Q, Jin T, et al
    Locoregional extension and patterns of failure for nasopharyngeal carcinoma with intracranial extension.
    Oral Oncol. 2018;79:27-32.
    PubMed     Text format     Abstract available


  153. VAISANEN JA, Alho OP, Koivunen PT, Laara E, et al
    Cause-specific mortality in patients with head and neck cancer: Long-term follow-up of a population-based cohort from 1986 to 2012 accounting for competing risks.
    Oral Oncol. 2018;79:20-26.
    PubMed     Text format     Abstract available


  154. KAMAL M, Ng SP, Eraj SA, Rock CD, et al
    Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer.
    Oral Oncol. 2018;79:1-8.
    PubMed     Text format     Abstract available


    March 2018
  155. GUPTA AA, Pande N, Kheur S, Raj AT, et al
    Assessing the potential role of scaffold-mediated local chemotherapy in oral cancer.
    Oral Oncol. 2018 Mar 16. pii: S1368-8375(18)30111.
    PubMed     Text format    


  156. MIZRACHI A, Migliacci JC, Montero PH, McBride S, et al
    Neck recurrence in clinically node-negative oral cancer: 27-year experience at a single institution.
    Oral Oncol. 2018;78:94-101.
    PubMed     Text format     Abstract available


  157. HAN MW, Ryu IS, Lee JC, Kim SH, et al
    Phosphorylation of PI3K regulatory subunit p85 contributes to resistance against PI3K inhibitors in radioresistant head and neck cancer.
    Oral Oncol. 2018;78:56-63.
    PubMed     Text format     Abstract available


  158. CHAN JYW, Wong STS, Wei WI
    Real time indocyanin green near infrared lymphangiography for the reduction of drainage volume after neck dissection.
    Oral Oncol. 2018;78:52-55.
    PubMed     Text format     Abstract available


  159. XU C, Sun R, Tang LL, Chen L, et al
    Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.
    Oral Oncol. 2018;78:37-45.
    PubMed     Text format     Abstract available


  160. LU S, Concha-Benavente F, Shayan G, Srivastava RM, et al
    STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV(+) status in head and neck cancer.
    Oral Oncol. 2018;78:186-193.
    PubMed     Text format     Abstract available


  161. PARK YP, Jin L, Bennett KB, Wang D, et al
    CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma.
    Oral Oncol. 2018;78:145-150.
    PubMed     Text format     Abstract available


  162. RETZBACH EP, Sheehan SA, Nevel EM, Batra A, et al
    Podoplanin emerges as a functionally relevant oral cancer biomarker and therapeutic target.
    Oral Oncol. 2018;78:126-136.
    PubMed     Text format     Abstract available


  163. BRANDAO NETO JS, Aires FT, Dedivitis RA, Matos LL, et al
    Comparison between magnetic resonance and computed tomography in detecting mandibular invasion in oral cancer: A systematic review and diagnostic meta-analysis: MRI x CT in mandibular invasion.
    Oral Oncol. 2018;78:114-118.
    PubMed     Text format     Abstract available


  164. SLOOTER MD, Handgraaf HJM, Boonstra MC, van der Velden LA, et al
    Detecting tumour-positive resection margins after oral cancer surgery by spraying a fluorescent tracer activated by gamma-glutamyltranspeptidase.
    Oral Oncol. 2018;78:1-7.
    PubMed     Text format     Abstract available


    February 2018
  165. MUMTAZ S, Parrish J, Singh M
    Oculosympathetic paresis after selective neck dissection: A 'distant' complication.
    Oral Oncol. 2018 Feb 16. pii: S1368-8375(18)30042.
    PubMed     Text format    


  166. GOPINATH D, Menon RK
    Comments on "Compositional and functional variations of oral microbiota associated with the mutational changes in oral cancer" by Yang et al.
    Oral Oncol. 2018 Feb 10. pii: S1368-8375(18)30052.
    PubMed     Text format    


  167. PAI SI, Jack Lee J, Carey TE, Westra WH, et al
    HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers.
    Oral Oncol. 2018;77:92-97.
    PubMed     Text format     Abstract available


  168. GIPSON BJ, Robbins HA, Fakhry C, D'Souza G, et al
    Sensitivity and specificity of oral HPV detection for HPV-positive head and neck cancer.
    Oral Oncol. 2018;77:52-56.
    PubMed     Text format     Abstract available


  169. HUO M, Panizza B, Bernard A, Porceddu SV, et al
    Head and neck squamous cell carcinoma of unknown primary: Outcomes of a pre-defined institutional treatment policy in a region with a high prevalence of skin cancer.
    Oral Oncol. 2018;77:43-48.
    PubMed     Text format     Abstract available


  170. MAJERCAKOVA K, Valero C, Lopez M, Garcia J, et al
    Postoperative staging of the neck dissection using extracapsular spread and lymph node ratio as prognostic factors in HPV-negative head and neck squamous cell carcinoma patients.
    Oral Oncol. 2018;77:37-42.
    PubMed     Text format     Abstract available


  171. KLEIN NULENT TJW, Noorlag R, Van Cann EM, Pameijer FA, et al
    Intraoral ultrasonography to measure tumor thickness of oral cancer: A systematic review and meta-analysis.
    Oral Oncol. 2018;77:29-36.
    PubMed     Text format     Abstract available


  172. AU KH, Ngan RKC, Ng AWY, Poon DMC, et al
    Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study).
    Oral Oncol. 2018;77:16-21.
    PubMed     Text format     Abstract available


  173. VAN DEN BOVENKAMP K, Dorgelo B, Noordhuis MG, van der Laan BFAM, et al
    Viable tumor in salvage neck dissections in head and neck cancer: Relation with initial treatment, change of lymph node size and human papillomavirus.
    Oral Oncol. 2018;77:131-136.
    PubMed     Text format     Abstract available


  174. DE FELICE F, de Vincentiis M, Luzzi V, Magliulo G, et al
    Late radiation-associated dysphagia in head and neck cancer patients: evidence, research and management.
    Oral Oncol. 2018;77:125-130.
    PubMed     Text format     Abstract available


  175. YANG SF, Huang HD, Fan WL, Jong YJ, et al
    Compositional and functional variations of oral microbiota associated with the mutational changes in oral cancer.
    Oral Oncol. 2018;77:1-8.
    PubMed     Text format     Abstract available


    January 2018
  176. WANG Y, Qin X, Zhu X, Chen W, et al
    Corrigendum to "Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway" [Oral Oncol. 76 (2018) 34-41].
    Oral Oncol. 2018 Jan 25. pii: S1368-8375(18)30015.
    PubMed     Text format    


  177. XU T, Zhou X, Shen C, Hu C, et al
    Suggestions for surveillance and radiation strategy in nasopharyngeal carcinoma treated with IMRT: Based on hazard-rate and patterns of recurrence.
    Oral Oncol. 2018;76:61-67.
    PubMed     Text format     Abstract available


  178. SZTURZ P, Wouters K, Kiyota N, Tahara M, et al
    Altered fractionation radiotherapy combined with concurrent low-dose or high-dose cisplatin in head and neck cancer: A systematic review of literature and meta-analysis.
    Oral Oncol. 2018;76:52-60.
    PubMed     Text format     Abstract available


  179. KUFTA K, Forman M, Swisher-McClure S, Sollecito TP, et al
    Pre-Radiation dental considerations and management for head and neck cancer patients.
    Oral Oncol. 2018;76:42-51.
    PubMed     Text format     Abstract available


  180. WANG Y, Qin X, Zhu X, Chen W, et al
    Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway.
    Oral Oncol. 2018;76:34-41.
    PubMed     Text format     Abstract available


  181. MARCAZZAN S, Varoni EM, Blanco E, Lodi G, et al
    Nanomedicine, an emerging therapeutic strategy for oral cancer therapy.
    Oral Oncol. 2018;76:1-7.
    PubMed     Text format     Abstract available


    December 2017
  182. VARELA-CENTELLES P, Garcia-Martin JM, Seoane-Romero J
    On the studies of time periods in head and neck cancer diagnosis and treatment.
    Oral Oncol. 2017 Dec 27. pii: S1368-8375(17)30415.
    PubMed     Text format    


  183. PENG H, Chen BB, Chen L, Chen YP, et al
    A network meta-analysis in comparing prophylactic treatments of radiotherapy-induced oral mucositis for patients with head and neck cancers receiving radiotherapy.
    Oral Oncol. 2017;75:89-94.
    PubMed     Text format     Abstract available


  184. VAN GINKEL JH, Slieker FJB, de Bree R, van Es RJJ, et al
    Cell-free nucleic acids in body fluids as biomarkers for the prediction and early detection of recurrent head and neck cancer: A systematic review of the literature.
    Oral Oncol. 2017;75:8-15.
    PubMed     Text format     Abstract available


  185. KULASINGHE A, Kenny L, Punyadeera C
    Circulating tumour cell PD-L1 test for head and neck cancers.
    Oral Oncol. 2017;75:6-7.
    PubMed     Text format     Abstract available


  186. JOSHI A, Patil V, Noronha V, Dhumal S, et al
    Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.
    Oral Oncol. 2017;75:54-60.
    PubMed     Text format     Abstract available


  187. CHENG SJ, Chang CF, Ko HH, Liu YC, et al
    Hypermethylated ZNF582 and PAX1 genes in oral scrapings collected from cancer-adjacent normal oral mucosal sites are associated with aggressive progression and poor prognosis of oral cancer.
    Oral Oncol. 2017;75:169-177.
    PubMed     Text format     Abstract available


  188. CHHABRIA KS, Carnaby GD
    Psychometric validation of the Center for Epidemiological Studies Depression Scale in Head and Neck Cancer patients.
    Oral Oncol. 2017;75:158-162.
    PubMed     Text format     Abstract available


  189. LI WF, Zhang Y, Liu X, Tang LL, et al
    Delayed clinical complete response to intensity-modulated radiotherapy in nasopharyngeal carcinoma.
    Oral Oncol. 2017;75:120-126.
    PubMed     Text format     Abstract available


  190. ASHIZAWA K, Yoshimura K, Johno H, Inoue T, et al
    Construction of mass spectra database and diagnosis algorithm for head and neck squamous cell carcinoma.
    Oral Oncol. 2017;75:111-119.
    PubMed     Text format     Abstract available


  191. KANG M, Zhou P, Liao X, Xu M, et al
    Prognostic value of masticatory muscle involvement in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
    Oral Oncol. 2017;75:100-105.
    PubMed     Text format     Abstract available


  192. PARK YM, Lee DY, Oh KH, Cho JG, et al
    Clinical implications of pathologic factors after thyroid lobectomy in patients with papillary thyroid carcinoma.
    Oral Oncol. 2017;75:1-5.
    PubMed     Text format     Abstract available


    November 2017
  193. RAJ AT, Patil S, Sarode SC, Sarode GS, et al
    Evaluating the association between household air pollution and oral cancer.
    Oral Oncol. 2017 Nov 11. pii: S1368-8375(17)30363.
    PubMed     Text format    


  194. ECONOMOPOULOU P, Kotsantis I, Kyrodimos E, Lianidou ES, et al
    Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
    Oral Oncol. 2017;74:83-89.
    PubMed     Text format     Abstract available


  195. FADEN DL, Thomas S, Cantalupo PG, Agrawal N, et al
    Multi-modality analysis supports APOBEC as a major source of mutations in head and neck squamous cell carcinoma.
    Oral Oncol. 2017;74:8-14.
    PubMed     Text format     Abstract available


  196. HAKANSSON K, Rasmussen JH, Rasmussen GB, Friborg J, et al
    A failure-type specific risk prediction tool for selection of head-and-neck cancer patients for experimental treatments.
    Oral Oncol. 2017;74:77-82.
    PubMed     Text format     Abstract available


  197. SZTURZ P, Budikova M, Vermorken JB, Horova I, et al
    Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data.
    Oral Oncol. 2017;74:68-76.
    PubMed     Text format     Abstract available


  198. WARD MC, Shah C, Adelstein DJ, Geiger JL, et al
    Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer.
    Oral Oncol. 2017;74:49-55.
    PubMed     Text format     Abstract available


  199. MI JL, Zhang B, Pan YF, Su YX, et al
    Chemotherapy regimens containing taxanes or fluorouracil in nasopharyngeal carcinoma: Which better?
    Oral Oncol. 2017;74:34-39.
    PubMed     Text format     Abstract available


  200. DIRVEN R, Ebrahimi A, Moeckelmann N, Palme CE, et al
    Tumor thickness versus depth of invasion - Analysis of the 8th edition American Joint Committee on Cancer Staging for oral cancer.
    Oral Oncol. 2017;74:30-33.
    PubMed     Text format     Abstract available


  201. AJMANI GS, Nocon CC, Wang CH, Bhayani MK, et al
    Assessment of adjuvant therapy in resected head and neck cancer with high-risk features.
    Oral Oncol. 2017;74:15-20.
    PubMed     Text format     Abstract available


  202. TAO Y, Gross N, Liu Y, Zhang L, et al
    A high ratio of IL-12Rbeta2-positive tumor-infiltrating lymphocytes indicates favorable prognosis in laryngeal cancer.
    Oral Oncol. 2017;74:148-156.
    PubMed     Text format     Abstract available


  203. BONOMO P, Desideri I, Loi M, Lo Russo M, et al
    Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?
    Oral Oncol. 2017;74:142-147.
    PubMed     Text format     Abstract available


  204. PAPAKOSTAS P, Tsaousi G, Stavrou G, Rachovitsas D, et al
    Percutaneous endoscopic gastrostomy feeding of locally advanced oro-pharygo-laryngeal cancer patients: Blenderized or commercial food?
    Oral Oncol. 2017;74:135-141.
    PubMed     Text format     Abstract available


  205. SU TL, Chen AN, Leong CP, Huang YC, et al
    The effect of home-based program and outpatient physical therapy in patients with head and neck cancer: A randomized, controlled trial.
    Oral Oncol. 2017;74:130-134.
    PubMed     Text format     Abstract available


  206. PATINO MA, Ramirez RE, Perez CA, Feng L, et al
    The impact of intraoperative opioid use on survival after oral cancer surgery.
    Oral Oncol. 2017;74:1-7.
    PubMed     Text format     Abstract available


    October 2017
  207. WU M, Ou D, He X, Hu C, et al
    Corrigendum to "Long-term results of a phase II study of gemcitabine and cisplatin chemotherapy combined with intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma" [Oral Oncol. 73 (2017) 118-123].
    Oral Oncol. 2017 Oct 11. pii: S1368-8375(17)30306.
    PubMed     Text format     Abstract available


  208. LI YC, Chen FP, Zhou GQ, Zhu JH, et al
    Incidence and dosimetric parameters for brainstem necrosis following intensity modulated radiation therapy in nasopharyngeal carcinoma.
    Oral Oncol. 2017;73:97-104.
    PubMed     Text format     Abstract available


  209. TSAI MS, Chen WC, Lai CH, Chen YY, et al
    Epigenetic therapy regulates the expression of ALDH1 and immunologic response: Relevance to the prognosis of oral cancer.
    Oral Oncol. 2017;73:88-96.
    PubMed     Text format     Abstract available


  210. WU SG, Liao XL, He ZY, Tang LY, et al
    Demographic and clinicopathological characteristics of nasopharyngeal carcinoma and survival outcomes according to age at diagnosis: A population-based analysis.
    Oral Oncol. 2017;73:83-87.
    PubMed     Text format     Abstract available


  211. HANNA GJ, Adkins DR, Zolkind P, Uppaluri R, et al
    Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma.
    Oral Oncol. 2017;73:65-69.
    PubMed     Text format     Abstract available


  212. NAKANO K, Marshall S, Taira S, Sato Y, et al
    A comparison of weekly paclitaxel and cetuximab with the EXTREME regimen in the treatment of recurrent/metastatic squamous cell head and neck carcinoma.
    Oral Oncol. 2017;73:21-26.
    PubMed     Text format     Abstract available


  213. KIYOTA N, Hasegawa Y, Takahashi S, Yokota T, et al
    A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141.
    Oral Oncol. 2017;73:138-146.
    PubMed     Text format     Abstract available


  214. WU M, Ou D, He X, Hu C, et al
    Long-term results of a phase II study of gemcitabine and cisplatin chemotherapy combined with intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Oral Oncol. 2017;73:118-123.
    PubMed     Text format    


  215. FARQUHAR DR, Divaris K, Mazul AL, Weissler MC, et al
    Poor oral health affects survival in head and neck cancer.
    Oral Oncol. 2017;73:111-117.
    PubMed     Text format     Abstract available


  216. HUANG SF, Hsiao JH, Young CK, Chien HT, et al
    Familial aggregation of nasopharyngeal carcinoma in Taiwan.
    Oral Oncol. 2017;73:10-15.
    PubMed     Text format     Abstract available


  217. ZHAN KY, Eskander A, Kang SY, Old MO, et al
    Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base.
    Oral Oncol. 2017;73:152-159.
    PubMed     Text format     Abstract available


    September 2017
  218. VEVE MP, Davis SL, Williams AM, McKinnon JE, et al
    Considerations for antibiotic prophylaxis in head and neck cancer surgery.
    Oral Oncol. 2017 Sep 21. pii: S1368-8375(17)30281.
    PubMed     Text format     Abstract available


  219. SAHOVALER A, Yeh D, Yoo J
    Primary facial reanimation in head and neck cancer.
    Oral Oncol. 2017 Sep 12. pii: S1368-8375(17)30246.
    PubMed     Text format     Abstract available


  220. DONA MG, Rollo F, Pichi B, Spriano G, et al
    Evaluation of the Xpert(R) HPV assay in the detection of Human Papillomavirus in formalin-fixed paraffin-embedded oropharyngeal carcinomas.
    Oral Oncol. 2017;72:117-122.
    PubMed     Text format     Abstract available


    July 2017
  221. BROGLIE MA, Jochum W, Michel A, Waterboer T, et al
    Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer.
    Oral Oncol. 2017;70:43-50.
    PubMed     Text format     Abstract available


    June 2017
  222. DABAS S, Gupta K, Ranjan R, Sharma AK, et al
    Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
    Oral Oncol. 2017;69:80-83.
    PubMed     Text format     Abstract available


    May 2017
  223. DODD RH, Forster AS, Waller J, Marlow LAV, et al
    Discussing HPV with oropharyngeal cancer patients: A cross-sectional survey of attitudes in health professionals.
    Oral Oncol. 2017;68:67-73.
    PubMed     Text format     Abstract available


    April 2017
  224. LEVI S, Zini A, Fischman S, Czerninski R, et al
    Epidemiology of oral, salivary gland and pharyngeal cancer in children and adolescents between 1970 and 2011.
    Oral Oncol. 2017;67:89-94.
    PubMed     Text format     Abstract available


  225. ZHANG Y, Waterboer T, Haddad RI, Miles BA, et al
    Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.
    Oral Oncol. 2017;67:77-82.
    PubMed     Text format     Abstract available


  226. CHAN OS, Kowanetz M, Ng WT, Koeppen H, et al
    Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer.
    Oral Oncol. 2017;67:52-60.
    PubMed     Text format     Abstract available


  227. LACAU ST GUILY J, Rousseau A, Baujat B, Perie S, et al
    Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study.
    Oral Oncol. 2017;67:29-36.
    PubMed     Text format     Abstract available


    March 2017
  228. PORCEDDU SV, Milne R, Brown E, Bernard A, et al
    Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy.
    Oral Oncol. 2017;66:81-86.
    PubMed     Text format     Abstract available


    February 2017
  229. GELTZEILER M, Clayburgh D, Gleysteen J, Gross ND, et al
    Predictors of extracapsular extension in HPV-associated oropharyngeal cancer treated surgically.
    Oral Oncol. 2017;65:89-93.
    PubMed     Text format     Abstract available


  230. GENTILE MS, Yip D, Liebsch NJ, Adams JA, et al
    Definitive proton beam therapy for adenoid cystic carcinoma of the nasopharynx involving the base of skull.
    Oral Oncol. 2017;65:38-44.
    PubMed     Text format     Abstract available


    January 2017
  231. O'HARE J, Maclean J, Szczesniak M, Gupta R, et al
    Laryngeal tumours and radiotherapy dose to the cricopharyngeus are predictive of death from aspiration pneumonia.
    Oral Oncol. 2017;64:9-14.
    PubMed     Text format     Abstract available


  232. OWOSHO AA, Tsai CJ, Lee RS, Freymiller H, et al
    The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.
    Oral Oncol. 2017;64:44-51.
    PubMed     Text format     Abstract available


  233. MARTEL M, Alemany L, Taberna M, Mena M, et al
    The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma.
    Oral Oncol. 2017;64:37-43.
    PubMed     Text format     Abstract available


    December 2016
  234. JEANNON JP, Tanaka A, Thavaraj S, Guerrero-Urbano T, et al
    ATR gene mutations in HPV negative oropharyngeal cancer.
    Oral Oncol. 2016 Dec 22. pii: S1368-8375(16)30244.
    PubMed     Text format    


  235. CHERA B, Wang K, Monroe A, Galloway T, et al
    Truth or myth: Definitive chemoradiotherapy doesn't work for HPV/p16 negative oropharyngeal squamous cell carcinoma?
    Oral Oncol. 2016 Dec 16. pii: S1368-8375(16)30234.
    PubMed     Text format    


    November 2016
  236. MIRGHANI H, Casiraghi O, Guerlain J, Amen F, et al
    Diagnosis of HPV driven oropharyngeal cancers: Comparing p16 based algorithms with the RNAscope HPV-test.
    Oral Oncol. 2016;62:101-108.
    PubMed     Text format     Abstract available


    September 2016
  237. D'SOUZA G, Zhang Y, Merritt S, Gold D, et al
    Patient experience and anxiety during and after treatment for an HPV-related oropharyngeal cancer.
    Oral Oncol. 2016;60:90-5.
    PubMed     Text format     Abstract available


  238. CHATURVEDI AK, D'Souza G, Gillison ML, Katki HA, et al
    Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. population.
    Oral Oncol. 2016;60:61-7.
    PubMed     Text format     Abstract available


    July 2016
  239. SABER CN, Gronhoj Larsen C, Dalianis T, von Buchwald C, et al
    Immune cells and prognosis in HPV-associated oropharyngeal squamous cell carcinomas: Review of the literature.
    Oral Oncol. 2016;58:8-13.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: